Effusion cytology of esophageal carcinoma

Cancer

Volumn 81, Issue 6, 1997, Pages 365-372

  Renshaw, Andrew A ^a,c   Nappi, Dorothy ^a   Sugarbaker, David J ^b   Swanson, Scott ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Cytology; Effusion; Esophageal neoplasms; Squamous cell carcinoma

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; EFFUSION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MALE; MESOTHELIUM CELL; PERICARDIAL EFFUSION; PERITONEUM EXUDATE; PLEURA EFFUSION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASCITIC FLUID; CARCINOMA, SQUAMOUS CELL; EPITHELIAL CELLS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; PLEURAL EFFUSION;

EID: 0031586633     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971225)81:6<365::AID-CNCR11>3.0.CO;2-X     Document Type: Article

References (29)

1. Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Washington, DC: Armed Forces Institute of Pathology, 1996.
2. Luse SA, Reagan JW. A histocytological study of effusions II. Effusions associated with malignant tumors. Cancer 1954;7:1167-81.
3. Ceelen GH. The cytologic diagnosis of ascitic fluid. Acta Cytol 1964;18:175-85.
4. Konikov N, Bleisch V, Piskie V. Prognostic significance of cytologic diagnoses of effusions. Acta Cytol 1966;10:335-9.
5. Johnson WD. The cytological diagnosis of cancer in serous effusions. Acta Cytol 1966;10:161-72.
6. Murphy WM, Ng ABP. Determination of primary site by examination of cancer cells in body fluids. Am J Clin Pathol 1972;58:479-88.
7. Yazdi HM, Hadju SI, Melamed MR. Cytopathology of pericardial effusions. Acta Cytol 1980;24:401-12.
8. Broghamer WL, Richardson ME, Faurrest SE. Malignancy-associated serosanguinous effusions. Acta Cytol 1984;28:46-50.
9. Johnston WW. The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-9.
10. Spieler P, Gloor F. Identification of types and primary sites of malignant tumors by examination of exfoliated tumor cells in serous fluids. Acta Cytol 1985;29:753-67.
11. Hsu C. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients. Diagn Cytopathol 1987;3:8-12.
12. Monte SA, Ehya H, Lang WR. Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987; 31:448-52.
13. Ringenberg QS, Doll DC, Loy TS, Yarbro JW. Malignant ascites of unknown origin. Cancer 1989;64:753-5.
14. Foot NC. Identification of types and primary sites of metastatic tumors from exfoliated cells in serous fluids. Am J Pathol 1954;30:661-77.
15. Sears D, Hadju SI. The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol 1987;31:85-97.
16. Smith-Purslow MJ, Kini SR, Naylor B. Cells of squamous cell carcinoma in pleural, peritoneal, and pericardial fluids. Acta Cytol 1989;33:245-53.
17. DiBonito L, Falconieri G, Colautti I, Bonifacio D, Dudine S. The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation. Acta Cytol 1992;36:329-32.
18. Yamada S, Takeda T, Matsumoto K. Prognostic analysis of malignant pleural and peritoneal effusions. Cancer 1983; 51:136-40.
19. Scholz J, Steinhofel U, Durig M, Prause A, Bause HW, Hamper K, et al. Postoperative pulmonary complications in patients with esophageal cancer. Clin Investig 1993;71:294-8.
20. Cwikiel M, Albertsson M, Hambraeus G. Acute and delayed effects of radiotherapy in patients with oesophageal squamous cell carcinoma treated with chemotherapy, surgery, and pre and postoperative radiotherapy. Acta Oncol 1994;33:49-53.
21. American Joint Committee on Cancer. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. Philadelphia: J. B. Lippincott, 1993.
22. Saphir O. Cytologic diagnosis of cancer from pleural and peritoneal fluids. Am J Clin Pathol 1949;19:309-14.
23. Foot NC. The identification of neoplastic cells in serous effusions. Am J Pathol 1956;32:961-77.
24. Edoute Y, Malberger E, Kuten A, Moscovitz M, Ben-haim SA. Symptomatic pericardial effusion in lung cancer patients: the role of fluid cytology. J Surg Oncol 1990;45:121-3.
25. Edoute Y, Kuten A, Ben-haim SA, Moscovitz M, Malberger E. Symptomatic pericardial effusion in breast cancer patients: the role of fluid cytology. J Surg Oncol 1990;45:265-9.
26. van de Molengraft FJJM, Voojis GP. Survival of patients with malignancy-associated effusions. Acta Cytol 1989;33:911-6.
27. Towers KJ, Melamed MR. Absence of prognostic features in the cytology of effusions due to mammary cancer. Acta Cytol 1979;23:30-4.
28. Wiley EL, Von Roenn J. Metastatic breast carcinoma in pleural fluid. Correlation of morphology with estrogen receptor activity and morphology of the primary carcinoma. Acta Cytol 1990;34:169-74.
29. Dieterich M, Goodman SN, Rojas-Corona RR, Emralion AB, Jimenez-Joseph D, Sherman ME. Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. Acta Cytol 1994;38:948-52.